Abstract:Burns are one of the most devastating injuries in the world, divided into superficial, partial-thickness (superficial or deep partial-thickness) and full-thickness burns. The current treatment of deep partial-thickness burns is mainly focused on preventing wound infections and less attention to the burn healing process. Therefore, it is imperative to develop medications aimed at promoting the stage of wound healing. It has been shown that epidermal growth factor (EGF) can promote the proliferation of various cells and it is known that tocotrienol-rich fraction (TRF) from palm oil has a strong antioxidant activity. Thus, a combination of EGF and TRF is included in the present formulation (EGF+TRF cream), which is expected to accelerate wound healing and inhibit oxidative stress in the burn. Deep partial-thickness burn wounds were produced on the dorsal part of Sprague-Dawley rats. Animals were then randomly divided into six groups: untreated, treated with Silverdin® cream, base cream, base cream with c% EGF, base cream with 3 % TRF or base cream with c% EGF and 3% TRF, respectively. Creams were applied once daily for 21 consecutive days. Digital images were captured daily for macroscopic evaluation. Six animals from each group were sacrificed on the 3rd, 7th, 11th, 14th and 21st day post-burn, harvesting skin tissues with the wound for histological, cellular, biochemical and gene expression analysis. Prior to the research of the EGF+TRF formulation in wound healing, a new apparatus was designed to create burn wounds. With this device, uniform deep partial-thickness burn was achieved with a contact temperature of 70°C, a fixed pressure of 300 g, and duration of 10 seconds. In addition, a novel histological scoring system was developed to make the evaluation process more systematic and reproducible. The chronological events in burn healing were initiated by the recruitment of neutrophils to the wound site on the 3rd day post-burn followed by the up-regulation of tumor necrosis factor-α (TNF-α) expression and rapid synthesis of collagens to facilitate leukocytes adhesion and crust attachment. The EGF+TRF treatment preceded this process and on the 7th day post-burn, wound contraction accelerated and the dermal healing was sped up by the proliferation of myofibroblasts and augmented expression of Collagen-1. By down regulation of interleukin 6 (IL-6) and TNF-α expression on Day 11 post-burn, the EGF+TRF treatment expedited the wound contraction and entering the re-modelling phase and arriving epithelialization on Day 14. This formulation was capable of promoting the recovery of the dermis and attenuate the oxidative stress by down regulating the expression of IL-6, TNF-α, inducible nitric oxide synthase (iNOS), matrix metalloproteinase-2 (MMP-2), tissue inhibitor of metalloproteinase-2 (TIMP-2), transforming growth factor-β1 (TGF-β1), vascular endothelial growth factor-A (VEGF-A) and Collagen-1. Finally, by Day 21 post-burn, the treatment of EGF+TRF formulation could advance the restoration of the epidermis and dermis and cut down the oxidative stress by down regulating the expression of IL-6 and iNOS. In conclusion, all results from the present study fully supported the beneficial application of EGF+TRF formulation in the treatment of deep-partial thickness burn, adhered to the mechanisms of burn healing process.

The Effect of an Autologous Protein-Based Topical Serum on Cutaneous Burns

Considerations on the Use of Platelet-Rich Plasma, Specifically for Burn Treatment

Potential therapeutic effects of topical recombinant human erythropoietin on burn wound healing: A preliminary randomized double-blind controlled clinical trial

Effectiveness of Autologous Platelet-Rich Plasma and Stromal Vascular Fraction in Autologous Skin Grafting

Radiosterilized Pig Skin, Silver Nanoparticles and Skin Cells as an Integral Dressing Treatment for Burns: Development, Pre-Clinical and Clinical Pilot Study

Therapeutic role of mesenchymal stem cells and platelet-rich plasma on skin burn healing and rejuvenation: A focus on scar regulation, oxido-inflammatory stress and apoptotic mechanisms

Efficacy Of Autologous Platelet-Rich Gel In The Treatment Of Deep Grade Ii Burn Wounds

Skin wound repair: Results of a pre-clinical study to evaluate electropsun collagen-elastin-PCL scaffolds as dermal substitutes

Evolution of a concept with enzymatic debridement and autologous in situ cell and platelet-rich fibrin therapy (BroKerF)

Efficacy of Lyophilised Platelet-Rich Plasma Powder on Healing Rate in Patients With Deep Second Degree Burn Injury: A Prospective Double-Blind Randomized Clinical Trial

Evaluation of a highly skin permeable low-molecular-weight protamine conjugated epidermal growth factor for novel burn wound healing therapy

92 Safety & Efficacy of Adipose-derived Stem Cells in Acute Burns: A Randomized Placebo-Controlled Phase-I Trial(ASCAB)

Role for platelet rich plasma as an adjuvant therapy in wound healing and burns

Fat Grafting and Regenerative Medicine in Burn Care

611 Comparison of Autologous Skin Cell Suspension to Conventional Surgical Treatment in Burn Patients

Healing properties of epidermal growth factor and tocotrienol-rich fraction formulation in deep partial-thickness burn wound model

Efficacy of neutral electrolyzed water vs. common topical antiseptics in the healing of full‑thickness burn: Preclinical trial in a mouse model

Treatment of superficial and deep partial width second degree burn's wound with allogeneic cord blood platelet gel

The Role of Platelet-Rich Plasma in Reducing Pain, Pruritus, and Improving Wound Healing of Skin Graft Donor Site

The Benefits of Using Platelet-rich Plasma with Dermal Substitutes for Extremity Posttraumatic Skin Defects: A Short-term Outcome

Topical Noneuphoric Phytocannabinoid Elixir 14 Reduces Inflammation and Mitigates Burn Progression